GGN Repeat Length and GGN/CAG Haplotype Variations in the Androgen Receptor Gene and Prostate Cancer Risk in South Indian Men

Overview

Journal J Hum Genet

Specialty Genetics

Date 2006 Sep 14

PMID 16969583

Citations 6

Authors

Krishnaswamy Vijayalakshmi

Kumarasamy Thangaraj

Singh Rajender

Venkatesan Vettriselvi

Perumal Venkatesan

Sunil Shroff

K N Vishwanathan

Solomon F D Paul

Affiliations

Soon will be listed here.

Abstract

The ethnic variation in the GGN and CAG microsatellites of the androgen receptor (AR) gene suggests their role in the substantial racial difference in prostate cancer risk. Hence, we performed a case-control study to assess whether GGN repeats independently or in combination with CAG repeats were associated with prostate cancer risk in South Indian men. The repeat lengths of the AR gene determined by Gene scan analysis, revealed that men with GGN repeats <or=21 had no significant risk compared to those with >21 repeats (OR 0.91 at 95% CI-0.52-1.58). However, when CAG repeats of our earlier study was combined with the GGN repeat data, the cases exhibited significantly higher frequency of the haplotypes CAG <or=19/GGN <or=21 (OR-5.2 at 95% CI-2.17-12.48, P < 0.001) and CAG <or=19/GGN > 21(OR-6.9 at 95%CI-2.85-17.01, P < 0.001) compared to the controls. No significant association was observed between GGN repeats and prostate-specific antigen levels and the age at diagnosis. Although a trend of short GGN repeats length in high-grade was observed, it was not significant (P = 0.09). Overall, our data reveals that specific GGN/CAG haplotypes (CAG <or=19/GGN <or=21 and CAG <or=19/GGN > 21) of AR gene increase the risk of prostate cancer and thus could serve as susceptibility marker for prostate cancer in South Indian men.

Citing Articles

Androgen receptor gene polymorphisms and risk of prostate cancer: a meta-analysis.

Weng H, Li S, Huang J, He Z, Meng X, Cao Y Sci Rep. 2017; 7:40554.

PMID: 28091563 PMC: 5238402. DOI: 10.1038/srep40554.

Testosterone level in men with type 2 diabetes mellitus and related metabolic effects: A review of current evidence.

Cheung K, Luk A, So W, Ma R, Kong A, Chow F J Diabetes Investig. 2015; 6(2):112-23.

PMID: 25802717 PMC: 4364844. DOI: 10.1111/jdi.12288.

Systematic review and meta-analysis of candidate gene association studies of lower urinary tract symptoms in men.

Cartwright R, Mangera A, Tikkinen K, Rajan P, Pesonen J, Kirby A Eur Urol. 2014; 66(4):752-68.

PMID: 24491308 PMC: 4410299. DOI: 10.1016/j.eururo.2014.01.007.

Ethnical disparities of prostate cancer predisposition: genetic polymorphisms in androgen-related genes.

Li J, Mercer E, Gou X, Lu Y Am J Cancer Res. 2013; 3(2):127-51.

PMID: 23593537 PMC: 3623834.

Decision tree-based modeling of androgen pathway genes and prostate cancer risk.

Barnholtz-Sloan J, Guan X, Zeigler-Johnson C, Meropol N, Rebbeck T Cancer Epidemiol Biomarkers Prev. 2011; 20(6):1146-55.

PMID: 21493872 PMC: 3111844. DOI: 10.1158/1055-9965.EPI-10-0996.

References

Lu S, Tsai S, Tsai M . Regulation of androgen-dependent prostatic cancer cell growth: androgen regulation of CDK2, CDK4, and CKI p16 genes. Cancer Res. 1997; 57(20):4511-6. View

Cunha G, Donjacour A, Cooke P, Mee S, Bigsby R, Higgins S . The endocrinology and developmental biology of the prostate. Endocr Rev. 1987; 8(3):338-62. DOI: 10.1210/edrv-8-3-338. View

Coetzee G, Ross R . Re: Prostate cancer and the androgen receptor. J Natl Cancer Inst. 1994; 86(11):872-3. DOI: 10.1093/jnci/86.11.872. View

Chamberlain N, Driver E, Miesfeld R . The length and location of CAG trinucleotide repeats in the androgen receptor N-terminal domain affect transactivation function. Nucleic Acids Res. 1994; 22(15):3181-6. PMC: 310294. DOI: 10.1093/nar/22.15.3181. View

Hsing A, Gao Y, Wu G, Wang X, Deng J, Chen Y . Polymorphic CAG and GGN repeat lengths in the androgen receptor gene and prostate cancer risk: a population-based case-control study in China. Cancer Res. 2000; 60(18):5111-6. View

Chang B, Zheng S, Hawkins G, Isaacs S, Wiley K, Turner A . Polymorphic GGC repeats in the androgen receptor gene are associated with hereditary and sporadic prostate cancer risk. Hum Genet. 2002; 110(2):122-9. DOI: 10.1007/s00439-001-0662-6. View

Stanford J, JUST J, Gibbs M, Wicklund K, Neal C, Blumenstein B . Polymorphic repeats in the androgen receptor gene: molecular markers of prostate cancer risk. Cancer Res. 1997; 57(6):1194-8. View

Forrest M, Edwards S, Houlston R, Kote-Jarai Z, Key T, Allen N . Association between hormonal genetic polymorphisms and early-onset prostate cancer. Prostate Cancer Prostatic Dis. 2005; 8(1):95-102. DOI: 10.1038/sj.pcan.4500785. View

Wohr G, Haussler J, Berthon P, Drelon E, Mangin P, Fournier G . (CAG)nCAA and GGN repeats in the human androgen receptor gene are not associated with prostate cancer in a French-German population. Eur J Hum Genet. 1999; 7(3):357-62. DOI: 10.1038/sj.ejhg.5200298. View

10.

Nwosu V, Carpten J, Trent J, Sheridan R . Heterogeneity of genetic alterations in prostate cancer: evidence of the complex nature of the disease. Hum Mol Genet. 2001; 10(20):2313-8. DOI: 10.1093/hmg/10.20.2313. View

11.

Mishra D, Thangaraj K, Mandhani A, Kumar A, Mittal R . Is reduced CAG repeat length in androgen receptor gene associated with risk of prostate cancer in Indian population?. Clin Genet. 2005; 68(1):55-60. DOI: 10.1111/j.1399-0004.2005.00450.x. View

12.

Platz E, Giovannucci E, Dahl D, Krithivas K, Hennekens C, Brown M . The androgen receptor gene GGN microsatellite and prostate cancer risk. Cancer Epidemiol Biomarkers Prev. 1998; 7(5):379-84. View

13.

Patrizio P, Leonard D, Chen K, Trounson A . Larger trinucleotide repeat size in the androgen receptor gene of infertile men with extremely severe oligozoospermia. J Androl. 2001; 22(3):444-8. View

14.

Jenster G, de Ruiter P, van der Korput H, Kuiper G, Trapman J, Brinkmann A . Changes in the abundance of androgen receptor isotypes: effects of ligand treatment, glutamine-stretch variation, and mutation of putative phosphorylation sites. Biochemistry. 1994; 33(47):14064-72. DOI: 10.1021/bi00251a015. View

15.

Gronberg H . Prostate cancer epidemiology. Lancet. 2003; 361(9360):859-64. DOI: 10.1016/S0140-6736(03)12713-4. View

16.

Miller E, Stanford J, Hsu L, Noonan E, Ostrander E . Polymorphic repeats in the androgen receptor gene in high-risk sibships. Prostate. 2001; 48(3):200-5. DOI: 10.1002/pros.1098. View

17.

Janne O, Palvimo J, Kallio P, Mehto M . Androgen receptor and mechanism of androgen action. Ann Med. 1993; 25(1):83-9. DOI: 10.3109/07853899309147863. View

18.

Chen C, Lamharzi N, Weiss N, Etzioni R, Dightman D, Barnett M . Androgen receptor polymorphisms and the incidence of prostate cancer. Cancer Epidemiol Biomarkers Prev. 2002; 11(10 Pt 1):1033-40. View

19.

Gao T, Marcelli M, McPhaul M . Transcriptional activation and transient expression of the human androgen receptor. J Steroid Biochem Mol Biol. 1996; 59(1):9-20. DOI: 10.1016/s0960-0760(96)00097-0. View

20.

IRVINE R, Yu M, Ross R, Coetzee G . The CAG and GGC microsatellites of the androgen receptor gene are in linkage disequilibrium in men with prostate cancer. Cancer Res. 1995; 55(9):1937-40. View